“ Chronic Hepatitis C Treatment for Genotype 2 or 3 in Brazil: Cost Effectiveness Analysis of Peginterferon Plus Ribavirin As First Choice Treatment ”. Brazilian Journal of Pharmaceutical Sciences, vol. 50, no. 2, Apr. 2014, pp. 345-52, https://doi.org/10.1590/S1984-82502014000200014.